PhRMA: 313 mental disorder treatments are in developmentWASHINGTON More than 300 medications for treating mental disorders are in development, according to a new report by a pharmaceutical industry lobbying group. J&J: Nucynta produced fewer side effects than competitor in trial Amgen gets priority review from FDA Kaletra-Isentress therapy for HIV patients as effective as standard treatments, drug makers say FDA accepts NDA for Eisai's Banzel FDA advisory committee shoots down Vivus' Qnexa Millipore officially becomes part of Merck KGaA Cardinal Health completes Healthcare Solutions Holding acquisition Mylan acquires Bioniche Pharma Watson inks deal with Itero First Previous 186 187 188 189 190 Next Last
